Meng L - Search Results

1

Implementation of a pathological diagnosis and treatment pathway may improve the molecular detection of lung cancer.

Shi C, Wei B, Liu X, Meng L, Zhao C, Chang Y, Sun R, Zhang Z, Yu Y, Ma J. Shi C, et al. Among authors: meng l. Ann Transl Med. 2022 Jan;10(2):45. doi: 10.21037/atm-21-6230. Ann Transl Med. 2022. PMID: 35282093 Free PMC article.

2

A new strategy in molecular typing: the accuracy of an NGS panel for the molecular classification of endometrial cancers.

Li Y, Feng J, Zhao C, Meng L, Shi S, Liu K, Ma J. Li Y, et al. Among authors: meng l. Ann Transl Med. 2022 Aug;10(16):870. doi: 10.21037/atm-22-3446. Ann Transl Med. 2022. PMID: 36111057 Free PMC article.

3

Co-targeting TMEM16A with a novel monoclonal antibody and EGFR with Cetuximab inhibits the growth and metastasis of esophageal squamous cell carcinoma.

Zheng Y, Meng L, Qu L, Zhao C, Wang L, Ma J, Liu C, Shou C. Zheng Y, et al. Among authors: meng l. J Transl Med. 2024 Nov 20;22(1):1046. doi: 10.1186/s12967-024-05830-3. J Transl Med. 2024. PMID: 39563381 Free PMC article.

4

Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer.

Li W, Wan R, Guo L, Chang G, Jiang D, Meng L, Ying J. Li W, et al. Among authors: meng l. BMC Med. 2022 May 10;20(1):160. doi: 10.1186/s12916-022-02362-9. BMC Med. 2022. PMID: 35534835 Free PMC article.

5

Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma.

Xing X, Lian S, Hu Y, Li Z, Zhang L, Wen X, Du H, Jia Y, Zheng Z, Meng L, Shou C, Ji J. Xing X, et al. Among authors: meng l. J Transl Med. 2013 Dec 13;11:309. doi: 10.1186/1479-5876-11-309. J Transl Med. 2013. PMID: 24330843 Free PMC article.

6

Targeting Claudin 18.2 Using a Highly Specific Antibody Enables Cancer Diagnosis and Guided Surgery.

Zhao C, Rong Z, Ding J, Wang L, Wang B, Ding L, Meng L, Meng X, Wang F, Yang Z, Shou C, Zhu H. Zhao C, et al. Among authors: meng x, meng l. Mol Pharm. 2022 Oct 3;19(10):3530-3541. doi: 10.1021/acs.molpharmaceut.1c00947. Epub 2022 Mar 28. Mol Pharm. 2022. PMID: 35344359

7

Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways.

Jia J, Martin TA, Ye L, Meng L, Xia N, Jiang WG, Zhang X. Jia J, et al. Among authors: meng l. Int J Mol Med. 2018 Jan;41(1):275-283. doi: 10.3892/ijmm.2017.3224. Epub 2017 Oct 27. Int J Mol Med. 2018. PMID: 29115573 Free PMC article.

8

A multi-targeting natural product, aiphanol, inhibits tumor growth and metastasis.

Chen SM, Feng JN, Zhao CK, Yao LC, Wang LX, Meng L, Cai SQ, Liu CY, Qu LK, Jia YX, Shou CC. Chen SM, et al. Among authors: meng l. Am J Cancer Res. 2022 Nov 15;12(11):4930-4953. eCollection 2022. Am J Cancer Res. 2022. PMID: 36504899 Free PMC article.

9

Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2.

Chen S, Feng J, Zhao C, Wang L, Meng L, Liu C, Cai S, Jia Y, Qu L, Shou C. Chen S, et al. Among authors: meng l. Signal Transduct Target Ther. 2021 Dec 3;6(1):413. doi: 10.1038/s41392-021-00739-5. Signal Transduct Target Ther. 2021. PMID: 34862391 Free PMC article. No abstract available.

10

Correction: Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2.

Chen S, Feng J, Zhao C, Wang L, Meng L, Liu C, Cai S, Jia Y, Qu L, Shou C. Chen S, et al. Among authors: meng l. Signal Transduct Target Ther. 2022 Apr 30;7(1):144. doi: 10.1038/s41392-022-00988-y. Signal Transduct Target Ther. 2022. PMID: 35490158 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,243 results

Search Page

Filters